What is the best end point for hepatitis B treatment?
Ann Intern Med
.
2008 Apr 1;148(7):560; author reply 560-1.
doi: 10.7326/0003-4819-148-7-200804010-00014.
Authors
Ching-Lung Lai
,
Man-Fung Yuen
PMID:
18378952
DOI:
10.7326/0003-4819-148-7-200804010-00014
No abstract available
Publication types
Comment
Letter
MeSH terms
Carrier State / drug therapy
Hepatitis B, Chronic / drug therapy*
Humans
Practice Guidelines as Topic / standards*